Singular Historical Income Statement

SHG Stock

0.11 0.01 8.33%

Historical analysis of Singular Health income statement accounts such as Selling General Administrative of 2.9 M, Selling And Marketing Expenses of 177.5 K, Total Revenue of 86.3 K or Other Operating Expenses of 4.5 M can show how well Singular Health Group performed in making a profits. Evaluating Singular Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Singular Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Singular Health Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Singular Health Group is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Singular Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Singular Income Statement Analysis

Singular Health Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Singular Health shareholders. The income statement also shows Singular investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Singular Health Income Statement Chart

At this time, Singular Health's Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 222.1 K in 2024, whereas Total Revenue is likely to drop slightly above 86.3 K in 2024.

Total Revenue Other Operating Expenses Ebitda

Total Revenue

Total revenue comprises all receipts Singular Health Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Singular Health Group. It is also known as Singular Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Singular Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Singular Health Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Singular Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	259.8K	389.1K	197.7K	222.1K
Interest Income	7.3K	485.8K	558.7K	586.6K

Depreciation And Amortization Interest Income

Singular Health income statement Correlations

	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Net Income From Continuing Ops	Research Development	Reconciled Depreciation
Interest Income		0.68	-0.03	0.52	0.49	0.39	-0.82	0.57	-0.58	-0.47	-0.45	0.78	-0.37	-0.39	0.56	-0.62	0.61	0.62	0.22	0.71	0.87
Depreciation And Amortization	0.68		0.28	0.93	0.67	0.65	-0.97	0.95	-0.95	-0.94	-0.93	0.98	0.37	-0.91	0.03	-0.92	0.43	0.89	-0.43	0.94	0.85
Interest Expense	-0.03	0.28		0.21	0.2	0.4	-0.29	0.33	-0.28	-0.32	-0.32	0.33	0.34	-0.49	-0.71	-0.4	0.45	-0.04	0.08	0.0	0.03
Selling General Administrative	0.52	0.93	0.21		0.85	0.35	-0.87	0.99	-0.99	-0.99	-0.99	0.85	0.6	-0.94	0.09	-0.96	0.48	0.96	-0.66	0.95	0.77
Selling And Marketing Expenses	0.49	0.67	0.2	0.85		-0.06	-0.71	0.83	-0.85	-0.81	-0.82	0.64	0.49	-0.76	0.29	-0.88	0.74	0.83	-0.47	0.79	0.73
Total Revenue	0.39	0.65	0.4	0.35	-0.06		-0.59	0.43	-0.4	-0.43	-0.41	0.69	0.02	-0.49	-0.42	-0.37	-0.08	0.28	0.01	0.4	0.44
Gross Profit	-0.82	-0.97	-0.29	-0.87	-0.71	-0.59		-0.92	0.92	0.87	0.86	-0.99	-0.19	0.84	-0.17	0.93	-0.59	-0.86	0.24	-0.92	-0.91
Other Operating Expenses	0.57	0.95	0.33	0.99	0.83	0.43	-0.92		-1.0	-0.99	-0.99	0.9	0.56	-0.97	0.03	-0.98	0.54	0.93	-0.57	0.93	0.79
Operating Income	-0.58	-0.95	-0.28	-0.99	-0.85	-0.4	0.92	-1.0		0.99	0.99	-0.89	-0.55	0.96	-0.07	0.98	-0.54	-0.95	0.58	-0.94	-0.81
Ebit	-0.47	-0.94	-0.32	-0.99	-0.81	-0.43	0.87	-0.99	0.99		1.0	-0.86	-0.65	0.98	0.05	0.96	-0.45	-0.92	0.66	-0.91	-0.74
Ebitda	-0.45	-0.93	-0.32	-0.99	-0.82	-0.41	0.86	-0.99	0.99	1.0		-0.85	-0.66	0.98	0.05	0.96	-0.45	-0.92	0.67	-0.91	-0.73
Cost Of Revenue	0.78	0.98	0.33	0.85	0.64	0.69	-0.99	0.9	-0.89	-0.86	-0.85		0.2	-0.84	0.06	-0.89	0.51	0.82	-0.23	0.9	0.9
Total Operating Expenses	-0.37	0.37	0.34	0.6	0.49	0.02	-0.19	0.56	-0.55	-0.65	-0.66	0.2		-0.69	-0.48	-0.49	0.01	0.44	-0.89	0.34	0.03
Income Before Tax	-0.39	-0.91	-0.49	-0.94	-0.76	-0.49	0.84	-0.97	0.96	0.98	0.98	-0.84	-0.69		0.22	0.95	-0.46	-0.83	0.61	-0.82	-0.66
Total Other Income Expense Net	0.56	0.03	-0.71	0.09	0.29	-0.42	-0.17	0.03	-0.07	0.05	0.05	0.06	-0.48	0.22		-0.06	0.29	0.33	0.15	0.31	0.4
Net Income	-0.62	-0.92	-0.4	-0.96	-0.88	-0.37	0.93	-0.98	0.98	0.96	0.96	-0.89	-0.49	0.95	-0.06		-0.68	-0.89	0.46	-0.9	-0.8
Income Tax Expense	0.61	0.43	0.45	0.48	0.74	-0.08	-0.59	0.54	-0.54	-0.45	-0.45	0.51	0.01	-0.46	0.29	-0.68		0.43	0.15	0.43	0.54
Net Interest Income	0.62	0.89	-0.04	0.96	0.83	0.28	-0.86	0.93	-0.95	-0.92	-0.92	0.82	0.44	-0.83	0.33	-0.89	0.43		-0.61	0.99	0.85
Net Income From Continuing Ops	0.22	-0.43	0.08	-0.66	-0.47	0.01	0.24	-0.57	0.58	0.66	0.67	-0.23	-0.89	0.61	0.15	0.46	0.15	-0.61		-0.51	-0.14
Research Development	0.71	0.94	0.0	0.95	0.79	0.4	-0.92	0.93	-0.94	-0.91	-0.91	0.9	0.34	-0.82	0.31	-0.9	0.43	0.99	-0.51		0.91
Reconciled Depreciation	0.87	0.85	0.03	0.77	0.73	0.44	-0.91	0.79	-0.81	-0.74	-0.73	0.9	0.03	-0.66	0.4	-0.8	0.54	0.85	-0.14	0.91

Click cells to compare fundamentals

Singular Health Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Singular Stock Analysis

When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Singular Historical Income Statement

About Singular Income Statement Analysis

Singular Health Income Statement Chart

Total Revenue

Other Operating Expenses

Singular Health income statement Correlations

Singular Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Singular Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tax Provision	Interest Income
Depreciation And Amortization	Interest Expense
Selling General Administrative	Selling And Marketing Expenses
Total Revenue	Gross Profit
Other Operating Expenses	Operating Income
Ebit	Ebitda
Cost Of Revenue	Total Operating Expenses
Income Before Tax	Total Other Income Expense Net
Net Income Applicable To Common Shares	Net Income
Income Tax Expense	Net Interest Income
Net Income From Continuing Ops	Research Development
Reconciled Depreciation

Ebitda	+ 1.0	Ebit
Other Operating Expenses	+ 0.99	Selling General Administrative
Ebit	+ 0.99	Operating Income
Ebitda	+ 0.99	Operating Income
Research Development	+ 0.99	Net Interest Income
Cost Of Revenue	+ 0.98	Depreciation And Amortization

Operating Income	- 1.0	Other Operating Expenses
Ebitda	- 0.99	Other Operating Expenses
Ebit	- 0.99	Other Operating Expenses
Cost Of Revenue	- 0.99	Gross Profit
Ebitda	- 0.99	Selling General Administrative
Ebit	- 0.99	Selling General Administrative